Prospective Study
Copyright ©The Author(s) 2019.
World J Clin Cases. Jun 6, 2019; 7(11): 1291-1301
Published online Jun 6, 2019. doi: 10.12998/wjcc.v7.i11.1291
Table 1 Baseline characteristics of patients in PiCCO and control groups
PiCCO group, n = 30Control group, n = 30P value
Age in yr76.37 ± 6.6775.93 ± 6.550.801
Male18 (60.0%)16 (53.3%)0.602
BMI24.89 ± 2.9024.50 ± 3.520.752
Comorbidities
Hypertension18 (60.0%)15 (50.0%)0.436
Hyperlipidemia8 (26.7%)7 (23.3%)0.766
Diabetes8 (26.7%)7 (23.3%)0.766
Pneumonia8 (26.7%)6 (20.0%)0.542
Respiratory failure3 (10.0%)4 (13.3%)0.688
APACHE II score24.07 ± 6.5426.03 ± 7.000.266
SOFA score10.07 ± 3.3410.09 ± 3.230.330
Hs-TnI in ng/mL0.39 ± 0.320.48 ± 0.320.304
NT-proBNP in pg/mL10459.47 ± 4784.8412871.13 ± 8681.390.189
PaO2/FiO2 in mmHg239.18 ± 96.67252.50 ± 109.640.619
Lac in mmol/L2.32 ± 1.132.40 ± 1.350.820